|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||163.39 - 164.62|
|52 Week Range||130.95 - 172.85|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.44%|
Cigna Group (NYSE: CI) agreed to acquire Express Scripts Holdings (NasdaqGS: ESRX), but healthcare sector-specific exchange traded funds remain relatively muted. For instance, the iShares U.S. Healthcare ...
The specter of legislative action on drug prices has faded in the past year, but high costs are still very much a concern for the medical community. Now, the U.S.'s largest hospitals have announced they’re planning to create a nonprofit generic drug company in response to high prices and shortages of some medical products. Leerink's Ami Fadia writes that the news is more evidence of an "increasingly competitive environment" in health care, especially for products that have limited competition, as the Food and Drug Administration has already emphasized accelerating its review process.
If someone had told you at the beginning of the year that the Republican-controlled Congress was going to try and fail to repeal and replace the Affordable Care Act (ACA) multiple times during 2017, you probably wouldn’t have believed them. You might think that this uncertainty would have taken a bearish toll on healthcare stocks, but you’d be wrong in most cases. Many healthcare stocks are keeping pace with, or outperforming, the S&P 500.
After many twists and turns, the strong momentum has started to build up in the healthcare space, pushing many stocks and ETFs to multi-year highs.
On March 24, 2017, House Speaker Paul Ryan pulled back the American Health Care Act, also known as "Trumpcare," before votes were cast.
CNBC's Mike Santoli takes a look at which ETFs could be affected by the announcement that J.P. Morgan, Berkshire Hathaway and Amazon are teaming up to form a health-care company.
Novartis got government approval for a new cancer therapy. The treatment will cost a staggering $475,000, and it will help children and young adults with a certain type of Leukemia. Yahoo Finance's Seana Smith, Nicole Smith and Rick Newman react to what Wall Street is saying about the drug.
Yahoo Finance's Alexis Christoforous is joined by Keith Bliss of Cuttone and Company from the floor of the New York Stock Exchange to discuss the proposed Senate bill that repeals and replaces Obamacare.